US Patent
US10130640 — Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid
Formulation · Assigned to Leo Pharma AS · Expires 2031-06-10 · 5y remaining
Vulnerability score
48/100
Strong — defensible against typical IPR challenges
What this patent protects
This patent protects a topical spray composition that combines a vitamin D derivative or analog with a corticosteroid for treating dermal diseases and conditions.
USPTO Abstract
The present invention relates to a topical spray composition comprising a biologically active vitamin D derivative or analog and a corticosteroid, and its use in the treatment of dermal diseases and conditions.
Drugs covered by this patent
- Diprolene (BETAMETHASONE DIPROPIONATE) · Merck & Co.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.